(A) Overall survival of MUC4/MUC16/MUC20 high and low risk groups in bladder cancer, colon cancer, lung adenocarcinoma, lung squamous adenocarcinoma, skin cancer and stomach cancer. This evidence concerns the gene MUC16 and urinary bladder carcinoma.